Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Promoting healthy skepticism in the news: helping journalists get it right.

Woloshin S, Schwartz LM, Kramer BS.

J Natl Cancer Inst. 2009 Dec 2;101(23):1596-9. doi: 10.1093/jnci/djp409. Epub 2009 Nov 20. No abstract available.

PMID:
19933445
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Re: Promoting healthy skepticism in the news: helping journalists get it right.

Bazell R.

J Natl Cancer Inst. 2010 Apr 21;102(8):575; author reply 575-8. doi: 10.1093/jnci/djq065. Epub 2010 Mar 23. No abstract available.

PMID:
20332389
[PubMed - indexed for MEDLINE]
Free Article
3.

Re: Promoting healthy skepticism in the news: helping journalists get it right.

Lash TL, Fox MP, Greenland S, Jurek AM, Hoggatt KJ, Cole SR, Maldonado G, Brooks D, Rothman KJ, Poole C.

J Natl Cancer Inst. 2010 Jun 2;102(11):829-30; author reply 830. doi: 10.1093/jnci/djq135. Epub 2010 Apr 26. No abstract available.

PMID:
20421568
[PubMed - indexed for MEDLINE]
Free Article
4.

Re: promoting healthy skepticism in the news: helping journalists get it right.

Pharoah PD.

J Natl Cancer Inst. 2011 Dec 21;103(24):1903; author reply 1903. doi: 10.1093/jnci/djr472. Epub 2011 Dec 12. No abstract available.

PMID:
22158126
[PubMed - indexed for MEDLINE]
Free Article
5.

PARP inhibitors in cancer: moving beyond BRCA.

Telli ML.

Lancet Oncol. 2011 Sep;12(9):827-8. doi: 10.1016/S1470-2045(11)70236-4. Epub 2011 Aug 19. No abstract available.

PMID:
21862406
[PubMed - indexed for MEDLINE]
6.

Medical research and the news media.

McGettigan P, Henry D.

N Engl J Med. 2005 Feb 24;352(8):838-9; author reply 838-9. No abstract available.

PMID:
15736294
[PubMed - indexed for MEDLINE]
7.

Medical research and the news media.

Finlayson ND, Nixon SJ, McAlister GW.

N Engl J Med. 2005 Feb 24;352(8):838-9; author reply 838-9. No abstract available.

PMID:
15728822
[PubMed - indexed for MEDLINE]
Free Article
8.

Poly(adp-ribose) polymerase inhibitors: a novel drug class with a promising future.

Gartner EM, Burger AM, Lorusso PM.

Cancer J. 2010 Mar-Apr;16(2):83-90. doi: 10.1097/PPO.0b013e3181d78223. Review.

PMID:
20404603
[PubMed - indexed for MEDLINE]
9.

View point. Journalists get it wrong about mental health mostly through ignorance, not malice, argues Shelley Jofre.

Jofre S.

Ment Health Today. 2005 Dec-2006 Jan:39. No abstract available.

PMID:
16379479
[PubMed - indexed for MEDLINE]
10.

BRCA-deficient and triple negative breast cancers: is olaparib effective in both subtypes?

Sahin I, Ararat E, Altundag K.

J BUON. 2011 Jan-Mar;16(1):184-5. No abstract available.

PMID:
21674877
[PubMed - indexed for MEDLINE]
11.

Poly (ADP-ribose) polymerase (PARP) inhibitors for the treatment of advanced germline BRCA2 mutant prostate cancer.

Sandhu SK, Omlin A, Hylands L, Miranda S, Barber LJ, Riisnaes R, Reid AH, Attard G, Chen L, Kozarewa I, Gevensleben H, Campbell J, Fenwick K, Assiotis I, Olmos D, Yap TA, Fong P, Tunariu N, Koh D, Molife LR, Kaye S, Lord CJ, Ashworth A, de Bono J.

Ann Oncol. 2013 May;24(5):1416-8. doi: 10.1093/annonc/mdt074. Epub 2013 Mar 22. No abstract available.

PMID:
23524863
[PubMed - indexed for MEDLINE]
Free Article
12.

How can we improve medical reporting? Let me count the ways.

Picard A.

Int J Health Serv. 2005;35(3):603-5.

PMID:
16119578
[PubMed - indexed for MEDLINE]
13.

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.

Audeh MW, Carmichael J, Penson RT, Friedlander M, Powell B, Bell-McGuinn KM, Scott C, Weitzel JN, Oaknin A, Loman N, Lu K, Schmutzler RK, Matulonis U, Wickens M, Tutt A.

Lancet. 2010 Jul 24;376(9737):245-51. doi: 10.1016/S0140-6736(10)60893-8. Epub 2010 Jul 6.

PMID:
20609468
[PubMed - indexed for MEDLINE]
14.

PARP inhibition in BRCA-mutated breast and ovarian cancers.

Chan SL, Mok T.

Lancet. 2010 Jul 24;376(9737):211-3. doi: 10.1016/S0140-6736(10)61119-1. No abstract available.

PMID:
20656109
[PubMed - indexed for MEDLINE]
15.

Human embryo research in the news: scientific versus ethical frames?

Evans W.

Am J Bioeth. 2004 Winter;4(1):9-10. No abstract available.

PMID:
15035921
[PubMed - indexed for MEDLINE]
16.

[PARP inhibitors to treat triple negative breast cancer].

Sugie T.

Gan To Kagaku Ryoho. 2010 Dec;37(13):2850-5. Review. Japanese. No abstract available.

PMID:
21235091
[PubMed - indexed for MEDLINE]
17.

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial.

Tutt A, Robson M, Garber JE, Domchek SM, Audeh MW, Weitzel JN, Friedlander M, Arun B, Loman N, Schmutzler RK, Wardley A, Mitchell G, Earl H, Wickens M, Carmichael J.

Lancet. 2010 Jul 24;376(9737):235-44. doi: 10.1016/S0140-6736(10)60892-6. Epub 2010 Jul 6.

PMID:
20609467
[PubMed - indexed for MEDLINE]
18.

Mechanisms of resistance to PARP inhibitors--three and counting.

Fojo T, Bates S.

Cancer Discov. 2013 Jan;3(1):20-3. doi: 10.1158/2159-8290.CD-12-0514.

PMID:
23319766
[PubMed - indexed for MEDLINE]
19.

Bias in journalistic accounts of embryo research reconsidered.

Baker R.

Am J Bioeth. 2004 Winter;4(1):15-6; discussion W31-2. No abstract available.

PMID:
15035926
[PubMed - indexed for MEDLINE]
20.

[How the media get the blame for everything].

van Maanen H.

Ned Tijdschr Geneeskd. 2012;156(39):A5329. Dutch.

PMID:
23009826
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk